{"uri":"bystander-receptor-blockade-ifn-r1-tnfrsf1a-icam-1-hw8b7hw","version_id":"0","protocol_name":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","protocol_name_html":"Bystander Receptor Blockade:  IFN\u03bbR1, TNFRSF1A, ICAM-1 and FAS","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"1","last_modified":"1517724003","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":"","public_fork_note":"","number_of_steps":"7","has_versions":"0","first_published_date":"1495050080","publish_date":"2017-05-17 19:41:20","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>This protocol describes the use of neutralizing antibodies to block receptrs for assessing involvement in bystander killing by\u00a0BiTE\u00ae-activated T cells.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":"","has_guidelines":"0","materials":[],"warning":"","version_class":"5824","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1494456282","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.hw8b7hw","doi_status":"2","changed_fork_steps":null,"profile_url":"x2y284w2t2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/006.png","full_name":"Sandra Ross","created_by":"Sandra Ross","private_link":"AE34843406657264AC88C12F298E8E8B","original_img":"1","username":"sandra-ross","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0183390","manuscript_citation":"Ross SL,  Sherman M,  McElroy PL,  Lofgren JA,  Moody G,  Baeuerle PA,  Coxon A,  Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE  12(8). doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0183390\">10.1371\/journal.pone.0183390<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":243361,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[{"protocol_name":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","protocol_name_html":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","uri":"collection-of-protocols-accompanying-bispecific-t-ib8carw","username":"sandra-ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","full_name":"Sandra Ross"}],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"4","badge_image":"\/img\/badges\/gold.svg","badge_description":"Gold power author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","authors_list":[{"name":"Sandra L. Ross","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Marika Sherman","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patricia L. McElroy","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Julie A. Lofgren","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Gordon Moody","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patrick A. Baeuerle","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Angela Coxon","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Tara Arvedson","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/006.png","username":"sandra-ross","full_name":"Sandra Ross","created_by":"Sandra Ross"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"","status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"496053","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"F0601A8C68F24E3BAAF8ADF6B3F67E19","previous_guid":null,"previous_id":"0","last_modified":"1494456282","components":[{"component_id":"801931","previous_id":0,"original_id":"0","guid":"A6696D47987B42F5905A4DDBBD916DDB","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"495\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"176\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>ViewPlate-96 black plate Packardview plate (imaging)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Perkin Elmer<\/p>\n<\/td>\n<td width=\"156\">\n<p>6005182<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Effector cells \u2013 unstimulated pan T cells<\/p>\n<\/td>\n<td width=\"176\">\n<p>AllCells<\/p>\n<\/td>\n<td width=\"156\">\n<p>PB009-1F<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Target cells \u2013 SW620, NUGC4<\/p>\n<\/td>\n<td width=\"176\">\n<p>Amgen cell bank<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>BiTE\u00aes \u2013 EGFR, MEC14<\/p>\n<\/td>\n<td width=\"176\">\n<p>Amgen<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>CellStripper\u2122 Dissociation Reagent nonenzymatic 1X<\/p>\n<\/td>\n<td width=\"176\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>25056Cl<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"176\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>50 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"176\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2070<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>15 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"176\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2096<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Growth medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>10% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Gibco<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>11875-093<\/p>\n<p>\u00a0<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Assay medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>1x nonessential amino acids (NEAA)<\/p>\n<p>10mM HEPES<\/p>\n<p>50\u00b5M 2-\u00df-mercaptoethanol<\/p>\n<p>1mM sodium pyruvate<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>5% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Biochrom<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Sigma<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>FG1215<\/p>\n<p>\u00a0<\/p>\n<p>11140-050<\/p>\n<p>15630-080<\/p>\n<p>M6250<\/p>\n<p>11360-070<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Recombinant IFN\u03bb<\/p>\n<\/td>\n<td width=\"176\">\n<p>Roche<\/p>\n<\/td>\n<td width=\"156\">\n<p>11040596001<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Recombinant TNF\u03b1<\/p>\n<\/td>\n<td width=\"176\">\n<p>Roche<\/p>\n<\/td>\n<td width=\"156\">\n<p>11371843001<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Hoechst 33342 nuclear dye<\/p>\n<\/td>\n<td width=\"176\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>62249<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Formaldeyde 16% (w\/v) methanol-free<\/p>\n<\/td>\n<td width=\"176\">\n<p>Pierce\/ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>28908<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human ICAM-1 neutralizing antibody (Clone 84H10)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Beckman Coulter<\/p>\n<\/td>\n<td width=\"156\">\n<p>IM0544<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human FAS neutralizing antibody (Clone ZB4)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Enzo<\/p>\n<\/td>\n<td width=\"156\">\n<p>227-E<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human FAS activating antibody (Clone CH11)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Millipore<\/p>\n<\/td>\n<td width=\"156\">\n<p>05-201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human IFN\u03bbR1 (Clone GIR208)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB6732<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human IFN\u03bbR1 (Clone 92101)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB6731<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human TNFRSF1A (Clone 16803)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB225<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Control mouse antibody muIgG1 (clone NCG01)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Abcam<\/p>\n<\/td>\n<td width=\"156\">\n<p>ab81032<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"495\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"176\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>ViewPlate-96 black plate Packardview plate (imaging)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Perkin Elmer<\/p>\n<\/td>\n<td width=\"156\">\n<p>6005182<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Effector cells \u2013 unstimulated pan T cells<\/p>\n<\/td>\n<td width=\"176\">\n<p>AllCells<\/p>\n<\/td>\n<td width=\"156\">\n<p>PB009-1F<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Target cells \u2013 SW620, NUGC4<\/p>\n<\/td>\n<td width=\"176\">\n<p>Amgen cell bank<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>BiTE\u00aes \u2013 EGFR, MEC14<\/p>\n<\/td>\n<td width=\"176\">\n<p>Amgen<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>CellStripper\u2122 Dissociation Reagent nonenzymatic 1X<\/p>\n<\/td>\n<td width=\"176\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>25056Cl<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"176\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>50 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"176\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2070<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>15 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"176\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2096<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Growth medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>10% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Gibco<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>11875-093<\/p>\n<p>\u00a0<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Assay medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>1x nonessential amino acids (NEAA)<\/p>\n<p>10mM HEPES<\/p>\n<p>50\u00b5M 2-\u00df-mercaptoethanol<\/p>\n<p>1mM sodium pyruvate<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>5% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Biochrom<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Sigma<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>FG1215<\/p>\n<p>\u00a0<\/p>\n<p>11140-050<\/p>\n<p>15630-080<\/p>\n<p>M6250<\/p>\n<p>11360-070<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Recombinant IFN\u03bb<\/p>\n<\/td>\n<td width=\"176\">\n<p>Roche<\/p>\n<\/td>\n<td width=\"156\">\n<p>11040596001<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Recombinant TNF\u03b1<\/p>\n<\/td>\n<td width=\"176\">\n<p>Roche<\/p>\n<\/td>\n<td width=\"156\">\n<p>11371843001<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Hoechst 33342 nuclear dye<\/p>\n<\/td>\n<td width=\"176\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>62249<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Formaldeyde 16% (w\/v) methanol-free<\/p>\n<\/td>\n<td width=\"176\">\n<p>Pierce\/ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>28908<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human ICAM-1 neutralizing antibody (Clone 84H10)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Beckman Coulter<\/p>\n<\/td>\n<td width=\"156\">\n<p>IM0544<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human FAS neutralizing antibody (Clone ZB4)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Enzo<\/p>\n<\/td>\n<td width=\"156\">\n<p>227-E<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human FAS activating antibody (Clone CH11)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Millipore<\/p>\n<\/td>\n<td width=\"156\">\n<p>05-201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human IFN\u03bbR1 (Clone GIR208)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB6732<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human IFN\u03bbR1 (Clone 92101)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB6731<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Mouse anti-human TNFRSF1A (Clone 16803)<\/p>\n<\/td>\n<td width=\"176\">\n<p>R&amp;D Systems<\/p>\n<\/td>\n<td width=\"156\">\n<p>MAB225<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"495\">\n<p>Control mouse antibody muIgG1 (clone NCG01)<\/p>\n<\/td>\n<td width=\"176\">\n<p>Abcam<\/p>\n<\/td>\n<td width=\"156\">\n<p>ab81032<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>"},"is_project":0},{"component_id":"801930","previous_id":"801931","original_id":"0","guid":"F1BD3666B2D54166BA00E8ACB6EF90ED","previous_guid":"A6696D47987B42F5905A4DDBBD916DDB","component_type_id":"6","data_id":"0","data":"Assemble Materials","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Assemble Materials"},"is_project":0}]},{"id":"496054","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"8481A03214554030AB99BADEB4B3CDE4","previous_guid":"F0601A8C68F24E3BAAF8ADF6B3F67E19","previous_id":"496053","last_modified":"1494456282","components":[{"component_id":"801933","previous_id":0,"original_id":"0","guid":"345983A8850B4651B7DB3BCA4B7241E0","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Day 1: \u00a0Combine EGFR<sup>+<\/sup> (NUGC4) + T cells (10:1 E:T) +\/- 100 pM EGFR BiTE\u00ae in T75 flask. Please refer to BiTE\u00ae bystander T cell dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 TDCC assay using BiTE\u00ae-activated T cells).<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Day 1: \u00a0Combine EGFR<sup>+<\/sup> (NUGC4) + T cells (10:1 E:T) +\/- 100 pM EGFR BiTE\u00ae in T75 flask. Please refer to BiTE\u00ae bystander T cell dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 TDCC assay using BiTE\u00ae-activated T cells).<\/p>"},"is_project":0},{"component_id":"801932","previous_id":"801933","original_id":"0","guid":"64A7BB047150495FAED7D20EA2979DF0","previous_guid":"345983A8850B4651B7DB3BCA4B7241E0","component_type_id":"6","data_id":"0","data":"Prepare BiTE\u00ae-activated and control T cells in bulk","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Prepare BiTE\u00ae-activated and control T cells in bulk"},"is_project":0}]},{"id":"496055","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"056C4058806E400C82F0702DE8C3777B","previous_guid":"8481A03214554030AB99BADEB4B3CDE4","previous_id":"496054","last_modified":"1494456282","components":[{"component_id":"801935","previous_id":0,"original_id":"0","guid":"4E039EA5585548D982928989F8812E34","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<h2>Day 1: \u00a0Prepare EGFR<sup>- <\/sup>(SW620) cells by plating 10,000 cells\/well in ViewPlate-96 black plates. Please refer to BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 prepare target cells). If blocking ICAM-1 or FAS, treat cells +\/- 10ng\/ml IFN\u03b3 and 5ng\/ml TNF\u03b1 for 24 hours.<\/h2>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<h2>Day 1: \u00a0Prepare EGFR<sup>- <\/sup>(SW620) cells by plating 10,000 cells\/well in ViewPlate-96 black plates. Please refer to BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 prepare target cells). If blocking ICAM-1 or FAS, treat cells +\/- 10ng\/ml IFN\u03b3 and 5ng\/ml TNF\u03b1 for 24 hours.<\/h2>"},"is_project":0},{"component_id":"801934","previous_id":"801935","original_id":"0","guid":"CDF47A1D21284365850C3B6234671DB0","previous_guid":"4E039EA5585548D982928989F8812E34","component_type_id":"6","data_id":"0","data":"Plate target cells","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Plate target cells"},"is_project":0}]},{"id":"496056","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"64488F60247F4467BF7BD699AC6BC238","previous_guid":"056C4058806E400C82F0702DE8C3777B","previous_id":"496055","last_modified":"1494456282","components":[{"component_id":"801937","previous_id":0,"original_id":"0","guid":"2600F8D2138F4FC2A0895558786F04BB","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Day 2:\u00a0 Harvest bulk BiTE\u00ae-activated and control T cells prepared in step 2. Please refer to BiTE\u00ae bystander T cell dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 TDCC assay using BiTE\u00ae-activated T cells). Resuspend cells at 2x10e6 cells\/ml (will use 50 \u00b5l\/well = 100,000 cells\/well)<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Day 2:\u00a0 Harvest bulk BiTE\u00ae-activated and control T cells prepared in step 2. Please refer to BiTE\u00ae bystander T cell dependent cellular cytotoxicity (TDCC) assay protocol (Step 5 \u2013 TDCC assay using BiTE\u00ae-activated T cells). Resuspend cells at 2x10e6 cells\/ml (will use 50 \u00b5l\/well = 100,000 cells\/well)<\/p>"},"is_project":0},{"component_id":"801936","previous_id":"801937","original_id":"0","guid":"BF66DAF64D3D4FDC8E59ADA163CE5612","previous_guid":"2600F8D2138F4FC2A0895558786F04BB","component_type_id":"6","data_id":"0","data":"Harvest BiTE\u00ae-activated and control T cells","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Harvest BiTE\u00ae-activated and control T cells"},"is_project":0}]},{"id":"496057","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"2815826C34A34EE1A6493BABDA0542B4","previous_guid":"64488F60247F4467BF7BD699AC6BC238","previous_id":"496056","last_modified":"1494456395","components":[{"component_id":"801939","previous_id":0,"original_id":"0","guid":"5F2CD7E465BF44958E026B273C9DCAC2","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Day 2:<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"204\">\n<p><strong>Antibody<\/strong><\/p>\n<\/td>\n<td width=\"78\">\n<p><strong>Clone #<\/strong><\/p>\n<\/td>\n<td>\n<p><strong>Final Conc.<\/strong><\/p>\n<\/td>\n<td>\n<p><strong>2X Conc.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-FAS blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>ZB4<\/p>\n<\/td>\n<td>\n<p>2.5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-ICAM-1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>84H10<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>10 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-IFN\u03bbR1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>GIR208<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-IFN\u03bbR1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>92101<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-TNFRSF1A blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>16803<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Control antibody<\/p>\n<\/td>\n<td width=\"78\">\n<p>NCG01<\/p>\n<\/td>\n<td>\n<p>2, 2.5, 5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4, 5, 10 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-FAS activating<\/p>\n<\/td>\n<td width=\"78\">\n<p>CH11<\/p>\n<\/td>\n<td>\n<p>2.5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Day 2:<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"204\">\n<p><strong>Antibody<\/strong><\/p>\n<\/td>\n<td width=\"78\">\n<p><strong>Clone #<\/strong><\/p>\n<\/td>\n<td>\n<p><strong>Final Conc.<\/strong><\/p>\n<\/td>\n<td>\n<p><strong>2X Conc.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-FAS blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>ZB4<\/p>\n<\/td>\n<td>\n<p>2.5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-ICAM-1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>84H10<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>10 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-IFN\u03bbR1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>GIR208<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-IFN\u03bbR1 blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>92101<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-TNFRSF1A blocking<\/p>\n<\/td>\n<td width=\"78\">\n<p>16803<\/p>\n<\/td>\n<td>\n<p>2 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Control antibody<\/p>\n<\/td>\n<td width=\"78\">\n<p>NCG01<\/p>\n<\/td>\n<td>\n<p>2, 2.5, 5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>4, 5, 10 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"204\">\n<p>Anti-FAS activating<\/p>\n<\/td>\n<td width=\"78\">\n<p>CH11<\/p>\n<\/td>\n<td>\n<p>2.5 \u00b5g\/ml<\/p>\n<\/td>\n<td>\n<p>5 \u00b5g\/ml<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"801938","previous_id":"801939","original_id":"0","guid":"6036552CE7E248A49D0D4EF9DC6DF5A9","previous_guid":"5F2CD7E465BF44958E026B273C9DCAC2","component_type_id":"6","data_id":"0","data":"Prepare 2X blocking antibody solutions in Assay Medium","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Prepare 2X blocking antibody solutions in Assay Medium"},"is_project":0}]},{"id":"496058","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"A43AA35770F84FF0A24812850F24A8AE","previous_guid":"2815826C34A34EE1A6493BABDA0542B4","previous_id":"496057","last_modified":"1494456419","components":[{"component_id":"801941","previous_id":0,"original_id":"0","guid":"8088110B89464B64984DB7CFA2F8710A","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Day 2:<\/p>\n<ol>\n<li>Remove medium from all wells<\/li>\n<li>Add 50 \u00b5l\/well 2X control or blocking antibody to designated wells; incubate for 1 hour at 37\u00b0C<\/li>\n<li>Add 50 \u00b5l\/well control or activated T cells prepared in Step 4 to designated wells (for E:T of 10:1, use 2x10e6 cells\/ml; 50 \u00b5l = 100,000 cells\/well). Note: BiTE\u00ae dilutions can be added to T cells prior to adding to assay plate.<\/li>\n<li>As a control for FAS activation, add 50 \u00b5l\/well Assay Medium + 50 \u00b5l\/well 2X FAS activating antibody to designated wells<\/li>\n<li>Incubate plates for 24 hours at 37\u00b0C<\/li>\n<\/ol>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Day 2:<\/p>\n<ol>\n<li>Remove medium from all wells<\/li>\n<li>Add 50 \u00b5l\/well 2X control or blocking antibody to designated wells; incubate for 1 hour at 37\u00b0C<\/li>\n<li>Add 50 \u00b5l\/well control or activated T cells prepared in Step 4 to designated wells (for E:T of 10:1, use 2x10e6 cells\/ml; 50 \u00b5l = 100,000 cells\/well). Note: BiTE\u00ae dilutions can be added to T cells prior to adding to assay plate.<\/li>\n<li>As a control for FAS activation, add 50 \u00b5l\/well Assay Medium + 50 \u00b5l\/well 2X FAS activating antibody to designated wells<\/li>\n<li>Incubate plates for 24 hours at 37\u00b0C<\/li>\n<\/ol>"},"is_project":0},{"component_id":"801940","previous_id":"801941","original_id":"0","guid":"EF30D05CB77C4B96B472E28353041583","previous_guid":"8088110B89464B64984DB7CFA2F8710A","component_type_id":"6","data_id":"0","data":"Set up assay","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Set up assay"},"is_project":0}]},{"id":"496059","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"4E5C92DF953A4516A151706332AC3088","previous_guid":"A43AA35770F84FF0A24812850F24A8AE","previous_id":"496058","last_modified":"1494456428","components":[{"component_id":"801943","previous_id":0,"original_id":"0","guid":"0AC7669707B3402AA86D73AB48AA5A61","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>Day 3: \u00a0Fix cells, stain nuclei with Hoechst nuclear dye and count 16 10X fields on ArrayScan using Target Activation bioapplication. Please refer to BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay protocol (Step 8 \u2013 Cytotoxicity assay).<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Day 3: \u00a0Fix cells, stain nuclei with Hoechst nuclear dye and count 16 10X fields on ArrayScan using Target Activation bioapplication. Please refer to BiTE\u00ae T cell-dependent cellular cytotoxicity (TDCC) assay protocol (Step 8 \u2013 Cytotoxicity assay).<\/p>"},"is_project":0},{"component_id":"801942","previous_id":"801943","original_id":"0","guid":"EF225851D2D940D8971151EB9548AAB5","previous_guid":"0AC7669707B3402AA86D73AB48AA5A61","component_type_id":"6","data_id":"0","data":"Measure cytotoxicity","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Measure cytotoxicity"},"is_project":0}]}]}